VIRCA NICHOLAS J 4
4 · HedgePath Pharmaceuticals, Inc. · Filed Mar 15, 2018
Insider Transaction Report
Form 4
VIRCA NICHOLAS J
DirectorPresident and CEO
Transactions
- Award
Common Stock Option
2018-03-13+310,000→ 310,000 totalExercise: $0.27From: 2018-03-13Exp: 2028-03-13→ Common Stock (310,000 underlying)